Key Takeaways

  • Abbott Capital advises pacing capital deployment evenly across four-year cycles because vintage year returns vary more widely than manager selection.
  • Public market outperformance has compressed private equity Public Market Equivalent (PME) outperformance spreads, raising the bar for LP re-commitments.
  • Jack Purcell estimates that 50,000 US companies generate between $50 million and $1 billion in annual revenue, with only a small fraction backed by institutional sponsors.
  • The operational transition from "just in time" to "just in case" supply chains favors domestic, founder-owned industrial and manufacturing assets over financial engineering.

The Dispersion Problem Across Fund Vintages

Private equity allocators often obsess over picking top-quartile managers while ignoring the macro timing of their capital calls. Young Lee challenges that instinct directly. He points out that broad macro conditions dictate vintage returns so heavily that vintage dispersion can wash out individual GP outperformance.

“Abbott's always preached be consistent in how much you invest,” Lee notes. “It's kind of like what Jack was saying, invest over four years. That's what we really value, that vintage year experience, 'cause look at the quartile rankings, sometimes the quartile matters more than the manager.”

When LPs try to time entry points based on interest rate cycles or market dips, they usually misjudge the pacing. A steady four-year commitment schedule forces programmatic dollar-cost averaging into private markets. Without it, an allocator risks over-allocating at market peaks and pulling back precisely when entry multiples reset.

The PME Squeeze and the Middle-Market Pool

For the past decade, institutional LPs accepted illiquidity and high fee loads because private equity reliably cleared public indices by 300 to 500 basis points. That spread narrowed as large-cap public equities surged.

Jack Purcell highlights the friction this creates during LP portfolio reviews: “I think part of that is just the relative performance to public equity returns, and the public equity returns have been exceptional, just exceptional. And so I think the benchmark, kind of the PME benchmark that private markets in general are up against, not only private equity, has just been really tricky the last couple years.”

When large-cap buyout funds look like levered beta plays against the S&P 500, they fail to justify their lockup periods. Lee makes the exact point: “If you're in a beta play of private equity, historically you have underperformed the public markets.”

Purcell sees the antidote in founder-owned, lower-middle-market businesses where valuations decouple from public indices. “There's 50,000 private companies with between 50 million of revenue and a billion of revenue on an annual basis in the US today,” Purcell says, “and a very small fraction of those is owned by private equity or other, other institutional asset owners.”

These targets also benefit from a domestic industrial shift. “For the longest time, people talked about just in time inventory. Now everyone talks about just in case inventory,” Purcell explains. “And this notion of a manufacturing resurgence in the US, I do think a lot of that is gonna benefit these more basic businesses.”

Why It Matters

Institutional allocators are consolidating their GP relationships into fewer, larger checks while demanding clear alpha over liquid benchmarks. For GPs, competing strictly on financial engineering or multiple expansion no longer clears the hurdle against index funds. Capital is shifting toward operational transformations in founder-led middle-market companies, where supply chain reshoring and direct platform integrations generate returns that public market beta cannot replicate.